Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas
- PMID: 38168059
- DOI: 10.22037/uj.v20i.7973
Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas
Abstract
Purpose: To evaluate the diagnostic accuracy of single and multiple fluorescence in situ hybridization (FISH) tests for upper urinary tract cancer (UTUC), we analyzed the diagnostic efficacy of FISH in patients with UTUC and the difference between it and the Tumor Node Metastasis (TNM) stage and grade of the tumor.
Materials and methods: Patients treated for UTUC at our institution between 2011 and 2021 who had not been previously diagnosed with UTUC were included. Patients were divided into single, two, and multiple (three times or four times) FISH groups based on the number of FISH tests performed on different samples from the same patient, and the diagnostic efficiency of single, two, and multiple FISH tests for muscle-invasive tumors and highgrade tumors were assessed.
Results: We included a total of 207 patients with UTUC, and when compared to single FISH, the sensitivity of multiple and double FISH for the diagnosis of UTUC increased from 62% to 76% and 78%, respectively. It went from 67% to 78% and 80% for muscle-invasive UTUC (> = pT2) and from 71% to 79% and 81% for the highest- grade UTUC.
Conclusion: Multiple FISH improves the diagnostic efficacy of UTUC and helps to differentiate aggressive tumors.
Similar articles
-
Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.Can J Urol. 2017 Feb;24(1):8620-8626. Can J Urol. 2017. PMID: 28263126
-
Does urinary cytology have a role in haematuria investigations?BJU Int. 2019 Jan;123(1):74-81. doi: 10.1111/bju.14459. Epub 2018 Aug 29. BJU Int. 2019. PMID: 30003675 Free PMC article.
-
Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study.BMC Urol. 2022 Nov 25;22(1):194. doi: 10.1186/s12894-022-01122-4. BMC Urol. 2022. PMID: 36434570 Free PMC article.
-
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC).Fr J Urol. 2024 Nov;34(12):102722. doi: 10.1016/j.fjurol.2024.102722. Fr J Urol. 2024. PMID: 39581669 Review.
-
Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.Urol Oncol. 2020 Jun;38(6):590-598. doi: 10.1016/j.urolonc.2020.01.008. Epub 2020 Feb 11. Urol Oncol. 2020. PMID: 32057596
MeSH terms
LinkOut - more resources
Full Text Sources
Medical